Physician profile
Eliezer Halpert
NPI 1881848687
$1,890.95
in general payments reported to CMS, 2019-2025
9 companies · $98.27 in 2025
The $98.27 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $384 · 2021: $302 · 2022: $44.01 · 2024: $17.47 · 2025: $98.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $471.77 | 2019-2021 | |
| Medtronic Vascular, INC. | $378.95 | 2019-2020 | |
| Boston Scientific Corporation | $370.27 | 2019-2024 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $270.33 | 2019-2020 | |
| Biocompatibles, INC. | $233.52 | 2019 | |
| Biotronik INC. | $98.27 | 2025 | Pulsar-18 T3, Pk Papyrus, Oscar |
| Terumo Medical Corporation | $29.77 | 2022 | |
| Avanir Pharmaceuticals, INC. | $23.83 | 2019 | |
| Angiodynamics, INC. | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliezer Halpert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.